Michael Ryskin
Stock Analyst at B of A Securities
(1.47)
# 3,553
Out of 5,124 analysts
39
Total ratings
52%
Success rate
-1.3%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Upgrades: Buy | $24 | $17.88 | +34.23% | 3 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Buy | $110 → $99 | $96.75 | +2.33% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $59.05 | +18.54% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $676.53 | -29.79% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $3.25 | +146.15% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $156.15 | +31.92% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $102.14 | -60.84% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $1.95 | +387.18% | 1 | Jun 25, 2024 | |
| CERT Certara | Maintains: Buy | $27 → $24 | $8.81 | +172.42% | 2 | Aug 15, 2023 | |
| AVTR Avantor | Maintains: Buy | $27 → $24 | $11.46 | +109.42% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $180 | $125.82 | +43.06% | 7 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.09 | - | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $3.49 | +186.53% | 2 | Nov 10, 2021 |
Schrödinger
Dec 15, 2025
Upgrades: Buy
Price Target: $24
Current: $17.88
Upside: +34.23%
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $96.75
Upside: +2.33%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $59.05
Upside: +18.54%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $676.53
Upside: -29.79%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.25
Upside: +146.15%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $156.15
Upside: +31.92%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $102.14
Upside: -60.84%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $1.95
Upside: +387.18%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $8.81
Upside: +172.42%
Avantor
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $11.46
Upside: +109.42%
Nov 4, 2022
Maintains: Buy
Price Target: $225 → $180
Current: $125.82
Upside: +43.06%
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.09
Upside: -
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $3.49
Upside: +186.53%